LEP and obesity due to melanocortin 4 receptor deficiency: Indeed, further clinical trials are needed to assess the selectivity and effectiveness of leptin-based therapy on weight loss regarding obesity, particularly defined the threshold of endogenous leptin level as a predictive factor for therapy response to determining the dose-response ratio of leptin-based therapy.